Acadia Pharma -18% on rumor but no hard news

Acadia Pharmaceuticals (ACAD -17.9%) shares are down sharply, with no recent news or information to account for the move, though biotech blogger Adam Feuerstein tweets a rumor that today's decline is due to a doctor on a Cowen panel having a bearish stance on its lead drug candidate pimavanserin.

Pimavanserin is in Phase 3 development as a potential first-in-class treatment for Parkinson's disease psychosis, and ACAD established an expedited path to an NDA filing in Q2.

Shares are up 403% YTD.

From other sites
Comments (11)
  • SMaturin
    , contributor
    Comments (2268) | Send Message


    He leads another bear raid.


    Just getting the job done.


    Well what did you expect?
    8 Oct 2013, 11:03 AM Reply Like
  • GaryLee276
    , contributor
    Comments (152) | Send Message
    Who leads another bear raid?


    What job is it getting done?


    What did you expect?
    8 Oct 2013, 11:09 AM Reply Like
  • Da Bing
    , contributor
    Comments (30) | Send Message
    Not super surprised here given RSI has been extremely high recently that said this could be a great time to buy on the dip
    8 Oct 2013, 11:18 AM Reply Like
  • fafatooey
    , contributor
    Comments (435) | Send Message
    What a gift. Just bought another 1,000
    8 Oct 2013, 11:30 AM Reply Like
  • bridge
    , contributor
    Comments (290) | Send Message
    Keep telling yourself that as it drops 25% in 3 days.
    9 Oct 2013, 01:03 PM Reply Like
  • johnnyhaha
    , contributor
    Comments (239) | Send Message
    Check his tweets again. He posted this: "None of the docs on Cowen panel taking place right now are slamming pimvanserin, according to a source on the scene".
    8 Oct 2013, 12:49 PM Reply Like
  • SMaturin
    , contributor
    Comments (2268) | Send Message
    Yep, got the job done. Now it's time to pump it.
    8 Oct 2013, 02:45 PM Reply Like
  • Trickdog
    , contributor
    Comments (581) | Send Message
    So, maybe one doctor (oh what a genius?) out of many thousands(that will prescribe Pima) says something, and people panic and sell for no good reason? Wow, what a lack of common sense the market has - it sure went up to near $30 for good reason people! When it sells billions of dollars of the drug you will likely regret selling it here.
    8 Oct 2013, 03:18 PM Reply Like
  • opar
    , contributor
    Comments (55) | Send Message
    Don't hold for long. I see further decline soon. I sold them allll at a high peak. lol
    10 Oct 2013, 03:49 AM Reply Like
  • wwrp
    , contributor
    Comments (6) | Send Message
    Cramer and Feurstein belong to the same brotherhood. Would love the Baker Bros to sue them for something..... anything.
    13 Oct 2013, 04:00 PM Reply Like
  • wwrp
    , contributor
    Comments (6) | Send Message
    Cramer, Feurstein , The Street belong to the same brotherhood.
    Be nice if the Baker Bros could sue the daylights out of them.
    13 Oct 2013, 04:03 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs